Pioglitazone in Clinical Practice: Where Are We Now?
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0001-z
- By:
- Publication type:
- Article
Works matching IS 18696953 AND DT 2012 AND VI 3 AND IP 1
Results: 14
1
2
Diabetic Macular Edema: Therapeutic Options.
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0002-y
- By:
- Publication type:
- Article
3
A Review of Exenatide: Optimizing Glycemic Control and Associated Cardiovascular Risk Factors in Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0003-x
- By:
- Publication type:
- Article
4
Management of Diabetic Foot Ulcers.
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0004-9
- By:
- Publication type:
- Article
5
Physician Reasons for Nonpharmacologic Treatment of Hyperglycemia in Older Patients Newly Diagnosed with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0005-8
- By:
- Publication type:
- Article
6
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study.
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0006-7
- By:
- Publication type:
- Article
7
Impact of Insulin Resistance, Body Mass Index, Disease Duration, and Duration of Metformin Use on the Efficacy of Vildagliptin.
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0008-5
- By:
- Publication type:
- Article
8
Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes.
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0007-6
- By:
- Publication type:
- Article
9
Clinical Outcomes After Insulin Initiation in Patients with Type 2 Diabetes: 24-Month Results from INSTIGATE.
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0009-4
- By:
- Publication type:
- Article
10
Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0010-y
- By:
- Publication type:
- Article
11
Effect of the Addition of Sitagliptin and Miglitol on Insulin-Treated Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0011-x
- By:
- Publication type:
- Article
12
Initial Sulfonylurea Use and Subsequent Insulin Therapy in Older Subjects with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0012-9
- By:
- Publication type:
- Article
13
Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial).
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0013-8
- By:
- Publication type:
- Article
14
Drug-Induced Generalized Skin Eruption in a Diabetes Mellitus Patient Receiving a Dipeptidyl Peptidase-4 Inhibitor Plus Metformin.
- Published in:
- Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0014-7
- By:
- Publication type:
- Article